A role of B cells in multiple sclerosis (MS) is well established, but there is limited understanding of their involvement during active disease. Here, we examined cerebrospinal fluid (CSF) and peripheral blood (PB) B cells in treatment-naive patients with MS or high-risk clinically isolated syndrome. Using flow cytometry, we found increased CSF lymphocytes with a disproportionate increase of B cells compared with T cells in patients with gadolinium-enhancing (Gd+) lesions on brain MRI. Ig gene heavy chain variable region (Ig-VH) repertoire sequencing of CSF and PB B cells revealed clonal relationships between intrathecal and peripheral B cell populations, which could be consistent with migration of B cells to and activation in the CNS in active MS. In addition, we found evidence for bystander immigration of B cells from the periphery, which could be supported by a CXCL13 gradient between CSF and blood. Understanding what triggers B cells to migrate and home to the CNS may ultimately aid in the rational selection of therapeutic strategies to limit progression in MS.
Erica L. Eggers, Brady A. Michel, Hao Wu, Sheng-zhi Wang, Carolyn J. Bevan, Aya Abounasr, Natalie S. Pierson, Antje Bischof, Max Kazer, Elizabeth Leitner, Ariele L. Greenfield, Stanislas Demuth, Michael R. Wilson, Roland G. Henry, Bruce A.C. Cree, Stephen L. Hauser, H.-Christian von Büdingen
Title and authors | Publication | Year |
---|---|---|
Multiple Sclerosis: A Story of the Interaction Between Gut Microbiome and Components of the Immune System.
Mohsen E, Haffez H, Ahmed S, Hamed S, El-Mahdy TS |
Molecular neurobiology | 2025 |
Intruders or protectors – the multifaceted role of B cells in CNS disorders
Aspden JW, Murphy MA, Kashlan RD, Xiong Y, Poznansky MC, Sîrbulescu RF |
Frontiers in cellular neuroscience | 2024 |
Peripheral memory B cells in multiple sclerosis vs. double negative B cells in neuromyelitis optica spectrum disorder: disease driving B cell subsets during CNS inflammation.
Tieck MP, Vasilenko N, Ruschil C, Kowarik MC |
Frontiers in cellular neuroscience | 2024 |
B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases.
Wang Q, Feng D, Jia S, Lu Q, Zhao M |
Clinical Reviews in Allergy & Immunology | 2024 |
CD11c(+) B cells in relapsing-remitting multiple sclerosis and effects of anti-CD20 therapy.
El Mahdaoui S, Hansen MM, von Essen MR, Hvalkof VH, Holm Hansen R, Mahler MR, Jennum P, Sellebjerg F, Romme Christensen J |
Annals of Clinical and Translational Neurology | 2024 |
Single-cell profiling indicates a high similarity between immune cells in the cerebrospinal fluid and in meningeal ectopic lymphoid tissue in experimental autoimmune encephalomyelitis
Georgieva T, Diddens J, Friedrich V, Lepennetier G, Brand RM, Lehmann-Horn K |
Frontiers in immunology | 2024 |
CXCL13: a common target for immune-mediated inflammatory diseases.
Hui L, Li Y, Huang MK, Jiang YM, Liu T |
Clinical and experimental medicine | 2024 |
Deciphering Autoimmune Diseases: Unveiling the Diagnostic, Therapeutic, and Prognostic Potential of Immune Repertoire Sequencing.
Hu Y, Huang J, Wang S, Sun X, Wang X, Yu H |
Inflammation | 2024 |
Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis
Vakrakou AG, Paschalidis N, Pavlos E, Giannouli C, Karathanasis D, Tsipota X, Velonakis G, Stadelmann-Nessler C, Evangelopoulos ME, Stefanis L, Kilidireas C |
Frontiers in immunology | 2023 |
Cladribine treatment specifically affects peripheral blood memory B cell clones and clonal expansion in multiple sclerosis patients
Ruschil C, Gabernet G, Kemmerer CL, Jarboui MA, Klose F, Poli S, Ziemann U, Nahnsen S, Kowarik MC |
Frontiers in immunology | 2023 |
Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes.
Ma Q, Shams H, Didonna A, Baranzini SE, Cree BAC, Hauser SL, Henry RG, Oksenberg JR |
Communications biology | 2023 |
The cerebrospinal fluid immune cell landscape in animal models of multiple sclerosis
Wu GF |
Frontiers in molecular neuroscience | 2023 |
Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial
Laurent SA, Strauli NB, Eggers EL, Wu H, Michel B, Demuth S, Palanichamy A, Wilson MR, Sirota M, Hernandez RD, Cree BA, Herman AE, von Büdingen HC |
Neurology: Neuroimmunology & Neuroinflammation | 2023 |
Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients
Telesford KM, Amezcua L, Tardo L, Horton L, Lund BT, Reder AT, Vartanian T, Monson NL |
Frontiers in immunology | 2023 |
Single-cell transcriptomics combined with proteomics of intrathecal IgG reveal transcriptional heterogeneity of oligoclonal IgG-secreting cells in multiple sclerosis
Polak J, Wagnerberger JH, Torsetnes SB, Lindeman I, Høglund RA, Vartdal F, Sollid LM, Lossius A |
Frontiers in cellular neuroscience | 2023 |
DAPTA, a C-C Chemokine Receptor 5 (CCR5), Leads to the Downregulation of Notch/NF-κB Signaling and Proinflammatory Mediators in CD40+ Cells in Experimental Autoimmune Encephalomyelitis Model in SJL/J Mice
Alghibiwi H, Ansari MA, Nadeem A, Algonaiah MA, Attia SM, Bakheet SA, Albekairi TH, Almudimeegh S, Alhamed AS, Shahid M, Alwetaid MY, Alassmrry YA, Ahmad SF |
Biomedicines | 2023 |
Do magnetic resonance imaging features differ between persons with multiple sclerosis of various races and ethnicities?
Nathoo N, Zeydan B, Neyal N, Chelf C, Okuda DT, Kantarci OH |
Frontiers in neurology | 2023 |
Genetic variation in the immunoglobulin heavy chain locus shapes the human antibody repertoire.
Rodriguez OL, Safonova Y, Silver CA, Shields K, Gibson WS, Kos JT, Tieri D, Ke H, Jackson KJL, Boyd SD, Smith ML, Marasco WA, Watson CT |
Nature Communications | 2023 |
Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment
Telesford KM, Smith C, Mettlen M, Davis MB, Cowell L, Kittles R, Vartanian T, Monson N |
2023 | |
Immunological defense of CNS barriers against infections
L Ampie, D McGavern |
Immunity | 2022 |
Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis
Hiromitsu Asashima, Pierre-Paul Axisa, Giang H. Pham, Erin E Longbrake, William E. Ruff, Nikhil Lele, Inessa Cohen, Khadir Raddassi, Tomokazu S. Sumida, David Hafler |
Journal of Clinical Investigation | 2022 |
The CXCL13/CXCR5 Immune Axis in Health and Disease-Implications for Intrathecal B Cell Activities in Neuroinflammation.
Harrer C, Otto F, Radlberger RF, Moser T, Pilz G, Wipfler P, Harrer A |
Cells | 2022 |
The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
C Veroni, F Aloisi |
Frontiers in immunology | 2021 |
Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
KD DiSano, F Gilli, AR Pachner |
Frontiers in immunology | 2021 |
B Cells in Neuroinflammation: New Perspectives and Mechanistic Insights
JJ Ahn, M Abu-Rub, RH Miller |
Cells | 2021 |
Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes
SS Soldan, C Su, RJ Lamontagne, N Grams, F Lu, Y Zhang, JD Gesualdi, DM Frase, LE Tolvinski, K Martin, TE Messick, JT Fingerut, E Koltsova, A Kossenkov, PM Lieberman, MA Luftig |
PLoS pathogens | 2021 |
Next Generation Sequencing of Cerebrospinal Fluid B Cell Repertoires in Multiple Sclerosis and Other Neuro-Inflammatory Diseases—A Comprehensive Review
C Ruschil, CL Kemmerer, L Beller, G Gabernet, MC Kowarik |
Diagnostics | 2021 |
Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities
F Otto, C Harrer, G Pilz, P Wipfler, A Harrer |
Diagnostics | 2021 |
Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease
JA Lopez, M Denkova, S Ramanathan, RC Dale, F Brilot |
IBMS BoneKEy | 2021 |
Longitudinal analysis of FcRL5 expression and clonal relationships among classical and atypical memory B cells following malaria
SJ Gonzales, S Bol, AE Braddom, R Sullivan, RA Reyes, I Ssewanyana, E Eggers, B Greenhouse, EM Bunnik |
Malaria Journal | 2021 |
B cells in central nervous system disease: diversity, locations and pathophysiology
RW Jain, VW Yong |
Nature Reviews Immunology | 2021 |
Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?
A Negron, O Stüve, TG Forsthuber |
Frontiers in neurology | 2020 |
Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire
N Belhouachi, A Xochelli, M Boudjoghra, C Lesty, N Cassoux, C Fardeau, TH Tran, S Choquet, B Sarker, C Houillier, A Alentorn, P LeHoang, C Soussain, V Touitou, H Merle-Beral, K Hoang-Xuan, B Bodaghi, K Stamatopoulos, F Davi |
Blood Advances | 2020 |
Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping
PA Hannikainen, P Kosa, C Barbour, B Bielekova |
Frontiers in neurology | 2020 |
B Cells in Multiple Sclerosis and Virus-Induced Neuroinflammation
R Chunder, V Schropp, S Kuerten |
Frontiers in neurology | 2020 |
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis
D Schafflick, CA Xu, M Hartlehnert, M Cole, A Schulte-Mecklenbeck, T Lautwein, J Wolbert, M Heming, SG Meuth, T Kuhlmann, CC Gross, H Wiendl, N Yosef, GM zu Horste |
Nature Communications | 2020 |
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
DS Lee, OL Rojas, JL Gommerman |
Nature Reviews Drug Discovery | 2020 |
A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells
E Gil-Varea, M Fedetz, H Eixarch, N Spataro, LM Villar, E Urcelay, A Saiz, Ó Fernández, L Leyva, L Ramió-Torrentà, K Vandenbroeck, D Otaegui, T Castillo-Triviño, G Izquierdo, S Malhotra, E Bosch, A Navarro, A Alcina, X Montalban, F Matesanz, M Comabella |
Journal of Clinical Medicine | 2020 |
A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis
A Ramesh, RD Schubert, AL Greenfield, R Dandekar, R Loudermilk, JJ Sabatino, MT Koelzer, EB Tran, K Koshal, K Kim, AK Pröbstel, D Banerji, CY Guo, AJ Green, RM Bove, JL DeRisi, JM Gelfand, BA Cree, SS Zamvil, SE Baranzini, SL Hauser, MR Wilson |
Proceedings of the National Academy of Sciences | 2020 |
Ocrelizumab zur Behandlung der Multiplen Sklerose
J Graf, P Albrecht, N Goebels, O Aktas, HP Hartung |
Der Nervenarzt | 2020 |
Gut microbiota–specific IgA + B cells traffic to the CNS in active multiple sclerosis
AK Pröbstel, X Zhou, R Baumann, S Wischnewski, M Kutza, OL Rojas, K Sellrie, A Bischof, K Kim, A Ramesh, R Dandekar, AL Greenfield, RD Schubert, JE Bisanz, S Vistnes, K Khaleghi, J Landefeld, G Kirkish, F Liesche-Starnecker, V Ramaglia, S Singh, EB Tran, P Barba, K Zorn, J Oechtering, K Forsberg, LR Shiow, RG Henry, J Graves, BA Cree, SL Hauser, J Kuhle, JM Gelfand, PM Andersen, J Schlegel, PJ Turnbaugh, PH Seeberger, JL Gommerman, MR Wilson, L Schirmer, SE Baranzini |
Science Immunology | 2020 |
Longitudinally persistent cerebrospinal fluid B-cells can resist treatment in multiple sclerosis
Ariele L Greenfield, Ravi Dandekar, Akshaya Ramesh, Erica L. Eggers, Hao Wu, Sarah A. Laurent, William Harkin, Natalie S. Pierson, Martin Weber, Roland G. Henry, Antje Bischof, Bruce A. Cree, Stephen Hauser, Michael R. Wilson, Hans-Christian von Büdingen |
JCI Insight | 2019 |
Induction of brain‐infiltrating T‐bet‐expressing B cells in multiple sclerosis
J Langelaar, L Rijvers, M Janssen, AF WierengaWolf, MJ Melief, TA Siepman, HE Vries, PP Unger, SM Ham, RQ Hintzen, MM Luijn |
Annals of Neurology | 2019 |
Understanding and measuring human B‐cell tolerance and its breakdown in autoimmune disease
KS Cashman, SA Jenks, MC Woodruff, D Tomar, CM Tipton, CD Scharer, FE Lee, JM Boss, I Sanz |
Immunological Reviews | 2019 |
Black African and Latino/a identity correlates with increased plasmablasts in MS
KM Telesford, UW Kaunzner, J Perumal, SA Gauthier, X Wu, I Diaz, M Kruse-Hoyer, C Engel, M Marcille, T Vartanian |
Neurology: Neuroimmunology & Neuroinflammation | 2019 |
Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis
KD DiSano, DB Royce, F Gilli, AR Pachner |
Frontiers in immunology | 2019 |
Plasma Cells, the Next Generation: Beyond Antibody Secretion
PD Pioli |
Frontiers in immunology | 2019 |
Antibody repertoire analysis in polygenic autoimmune diseases
RJ Bashford-Rogers, KG Smith, DC Thomas |
Immunology | 2018 |
The role of B cells in multiple sclerosis: current and future therapies
A Negron, RR Robinson, O Stuve, TG Forsthuber |
Cellular Immunology | 2018 |
B-cell Therapy for Multiple Sclerosis: Entering an era: MS: Entering the Era of B-Cell Therapy
AL Greenfield, SL Hauser |
Annals of Neurology | 2018 |
Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis
H Touil, A Kobert, N Lebeurrier, A Rieger, P Saikali, C Lambert, L Fawaz, CS Moore, A Prat, J Gommerman, JP Antel, Y Itoyama, I Nakashima, A Bar-Or |
Journal of Neuroinflammation | 2018 |
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
B Ceronie, BM Jacobs, D Baker, N Dubuisson, Z Mao, F Ammoscato, H Lock, HJ Longhurst, G Giovannoni, K Schmierer |
Journal of Neurology | 2018 |
Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis
Londoño AC, Mora CA |
F1000Research | 2018 |